Efficacy and Safety of Postdischarge Administration of Enoxaparin in the Prevention of Deep Venous Thrombosis after Total Hip Replacement
- 1 January 1996
- journal article
- clinical trial
- Published by Springer Nature in Drugs
- Vol. 52 (Supplement) , 47-54
- https://doi.org/10.2165/00003495-199600527-00009
Abstract
Although venous thromboembolism has occasionally been reported after hospital discharge in patients who have undergone total hip replacement (THR), this risk has not been fully quantified and the...Keywords
This publication has 34 references indexed in Scilit:
- A Comparison of Subcutaneous Low-Molecular-Weight Heparin with Warfarin Sodium for Prophylaxis against Deep-Vein Thrombosis after Hip or Knee ImplantationNew England Journal of Medicine, 1993
- Elective total hip replacement: incidence, emergency readmission rate, and postoperative mortality.BMJ, 1991
- Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.BMJ, 1991
- Low-molecular-weight heparin (enoxaparin) vs dextran 70. The prevention of postoperative deep vein thrombosis after total hip replacement. The Danish Enoxaparin Study GroupArchives of internal medicine (1960), 1991
- Thrombosis after hip replacement: Relationship to the fibrinolytic systemActa Orthopaedica, 1989
- The relationship between plasma vasopressin and changes in coagulation and fibrinolysis during hip surgeryThrombosis Research, 1988
- Deep venous thrombosis: a continuing problem.BMJ, 1988
- Prevention of thrombosis after hip arthroplastyActa Orthopaedica, 1988
- Fibrinolytic shut‐down after surgery: impairment of the balance between tissue‐type plasminogen activator and its specific inhibitorEuropean Journal of Clinical Investigation, 1985
- Femoral vein thrombosis and total hip replacement.BMJ, 1977